Column

Do Not Mistake Slowly Progressive Shoulder Osteoarthritis in Patients Over 60 for Frozen Shoulder — Dr. Moriwaki Organizes What Joint Space Narrowing and Inferior Osteophytes Reveal About Primary Glenohumeral Degeneration, and What Intra-Articular Inflammation Control Stem Cell Conditioned Media Shoulder Injections Can Realistically Target2026.07.29

When patients over 60 present with “I can’t lift my shoulder” or “my shoulder aches at night and I can’t sleep,” they are often told “it’s frozen shoulder.” Yet behind that pain, shoulder osteoarthritis — primary osteoarthritis of the glenohumeral joint — is not uncommonly hiding. Whereas frozen shoulder tends to resolve spontaneously over roughly one to two years, shoulder osteoarthritis progresses slowly through cartilage wear and joint space narrowing that does not spontaneously recover, so the clinical course and treatment design should really be considered as different problems. In this article, Dr. Shin Moriwaki of AVAN TOKYO Ginza honestly organizes the clinical lens to distinguish the two, and what stem cell conditioned media shoulder injections can and cannot realistically target.

Key Points

・Shoulder osteoarthritis is common in patients over 60. It is a progressive disease in which the cartilage of the glenohumeral joint wears down and the joint space narrows.

・Its symptoms overlap with frozen shoulder, but while frozen shoulder tends to recover on its own, shoulder osteoarthritis does not spontaneously recover.

・The diagnostic backbone is confirming joint space narrowing, inferior osteophytes, and subchondral sclerosis on plain radiographs.

・Stem cell conditioned media shoulder injection aims to act on intra-articular synovitis and the inflammatory environment. It is not a treatment that regenerates worn cartilage itself.

・In cases of severe joint destruction, massive rotator cuff tears, or active infection, it is not appropriate — orthopedic interventions such as shoulder arthroplasty take priority.

What Is Shoulder Osteoarthritis?

Shoulder osteoarthritis is a disease in which the cartilage of the glenohumeral joint — formed by the humeral head and the glenoid — wears down, the joint space narrows, and osteophytes and subchondral sclerosis develop over time. Its frequency tends to be underestimated compared with knee or hip osteoarthritis, but now that plain radiography, ultrasound, and MRI evaluation have become widespread, it is increasingly recognized as accounting for a non-trivial share of chronic shoulder pain in patients over 60. The shoulder is not a weight-bearing joint, but it is a joint that demands a very wide range of motion, so even a modest advance in cartilage wear or osteophyte formation strongly restricts daily activities such as hairdressing, back-hooking, and overhead reaching.

Differences from Frozen Shoulder

Frozen shoulder (adhesive capsulitis) typically arises in the 40s to 60s and tends to resolve spontaneously over roughly one to two years, passing through inflammatory, frozen, and thawing phases. Shoulder osteoarthritis, by contrast, does not spontaneously recover. Both present with night pain and restricted range of motion, so distinguishing them at the first visit based on history and examination alone is not easy. Evaluating the joint space on plain radiographs is the first step in separating the two.

Joint Space Narrowing and Inferior Osteophytes as Signs

Typical imaging findings of shoulder osteoarthritis include joint space narrowing, an inferior osteophyte (the so-called “goat’s beard” sign), subchondral sclerosis, and sometimes intra-articular loose bodies. As long as the joint space is preserved, options remain broad. Once the humeral head contacts the glenoid and the joint space is essentially lost, the treatment strategy changes considerably.

shoulder osteoarthritis stem cell supernatant injection

Symptoms and the Diagnostic Flow

The clinical entry point is shoulder pain on motion and restricted range of motion that progresses slowly over months to years. External rotation restriction (difficulty with hairdressing) and abduction restriction (difficulty with overhead reach) are especially prominent. When patients report inability to lay the arm out to the side while supine, or being woken by pain when rolling over, we consider that they have entered a phase where intra-articular inflammation control is needed. For clinical information on joint disease, guidelines and resources from the Japanese Orthopaedic Association are also worth consulting when we make individual indication decisions.

How the Range of Motion Limitation Manifests

A characteristic of shoulder osteoarthritis is that both passive and active range of motion decline to a comparable degree. This overlaps with the frozen phase of frozen shoulder, so range of motion assessment alone cannot always distinguish the two. When the joint space is already narrowed, aggressive range-of-motion training tends to worsen pain, so the intensity of rehabilitation must be designed carefully.

What to Confirm on Imaging

On plain anteroposterior and axial views we confirm joint space narrowing, inferior osteophytes, and subchondral cysts, and if needed we evaluate the degree of synovitis and the state of the rotator cuff on MRI. Once the disease has progressed to cuff tear arthropathy — with a massive rotator cuff tear and superior migration of the humeral head — the treatment design changes from the ground up.

What Stem Cell Conditioned Media Shoulder Injection Can Realistically Target

Stem cell conditioned media is a preparation refined from the culture supernatant (secretome) of stem cells, containing anti-inflammatory cytokines and growth factors such as IGF-1, TGF-β, and HGF. In the setting of shoulder osteoarthritis, what a shoulder injection aims for is intra-articular synovitis control and rebalancing of the inflammatory cytokine environment of the joint.

Mechanism and the Response We Anticipate

It has become increasingly clear that pain in osteoarthritis derives less from cartilage itself and more from synovitis and an inflammatory cytokine environment centered on IL-1β and TNF-α. Stem cell conditioned media shoulder injection is presumed, mechanistically, to act on the balance of this inflammatory cascade. However, since it is not a treatment that restores worn cartilage or a lost joint space, expectations should be set on “calibrating the baseline of inflammation and pain and creating a state in which range-of-motion training can be advanced.”

Non-Indication and Limitations: An Honest Line

In patients with advanced joint destruction where the humeral head and glenoid are in bone-to-bone contact, in cuff tear arthropathy with massive rotator cuff tears, in active septic arthritis, and in patients with poorly controlled systemic disease, stem cell conditioned media shoulder injection is not the first choice — even when the diagnosis is shoulder osteoarthritis. Based on orthopedic evaluation, options including shoulder arthroplasty (TSA, reverse TSA) should be considered first.

Comparison and Combination with Other Injections and Conservative Care

For mild to moderate shoulder osteoarthritis, oral NSAIDs, exercise therapy to restore range of motion and scapulothoracic rhythm, and — where appropriate — corticosteroid or hyaluronic acid shoulder injections come up as options. Corticosteroids have a strong anti-inflammatory effect, but concerns about their impact on cartilage and tendons with repeated administration mean that interval and number of doses have to be designed carefully. Stem cell conditioned media shoulder injection is positioned as a combination option with existing treatments, or as an option for patients who wish to avoid repeated corticosteroid injections. For related treatment background, please also see our page on stem cell conditioned media joint injection.

Whichever option is chosen, it is essential not to complete treatment with “just the injection” but to run exercise therapy in parallel to preserve external rotator function and scapulothoracic joint mobility, which is indispensable for long-term shoulder function.

Frequently Asked Questions

Q. Can I tell shoulder osteoarthritis and frozen shoulder apart myself?

Because symptoms overlap heavily, self-judgment is genuinely difficult. If you are over 60 with shoulder pain, particularly with strong external rotation restriction and gradual progression over several months, we recommend having your joint space evaluated on a plain radiograph early.

Q. Will stem cell conditioned media shoulder injection restore cartilage?

It is not a treatment that restores worn cartilage or a lost joint space. The aim is to modulate the intra-articular inflammatory environment and lower the baseline of pain. Effect varies between individuals, and the range that can be expected changes with disease progression.

Q. How many injections are typical?

The number and interval are designed while evaluating disease stage, pain, and range of motion. A common approach is several sessions in the induction phase followed by longer maintenance intervals, but if response is poor, switching to continuation, change of treatment, or orthopedic re-evaluation is equally important.

Q. Surgery has already been recommended — can I still stretch things out with injections?

Multiple factors are weighed: the progression of joint destruction, how much daily activities are impaired by pain, age, and activity level. At the stage where shoulder arthroplasty is appropriate, continuing to lean on injections is not necessarily in the patient’s interest. A second opinion — getting perspectives from both your orthopedic surgeon and a physician who handles stem cell conditioned media — is also useful.

Q. Which should be prioritized, rehabilitation or injection?

We recommend running them together rather than choosing one or the other. Suppressing inflammation and pain with injection while running exercise therapy in parallel to maintain range of motion and scapulothoracic rhythm tends to yield the greatest functional improvement.

──────────────

【監修】森脇 進 / Shin Moriwaki (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Joint Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcome via DM / LINE / Website / Phone.